Molecular Basis of Parathyroid Hyperplasia

Journal of Renal Nutrition

Volumn 17, Issue 1, 2007, Pages 45-47

  Dusso, Adriana S ^a   Arcidiacono, Maria Vittoria ^a   Sato, Tetsuhiko ^a,b   Alvarez Hernandez, Daniel ^a   Yang, Jing ^a   Gonzalez Suarez, Ignacio ^a   Tominaga, Yoshihiro ^b   Slatopolsky, Eduardo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE MODEL; HUMAN; METABOLIC BONE DISEASE; METABOLISM; PATHOPHYSIOLOGY; RAT; SECONDARY HYPERPARATHYROIDISM;

ANIMALS; BONE DISEASES, METABOLIC; CCAAT-ENHANCER-BINDING PROTEIN-BETA; DISEASE MODELS, ANIMAL; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PROTEIN ISOFORMS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 33845760490     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.10.021     Document Type: Article

References (14)

1. Slatopolsky E., Brown A., and Dusso A. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 37 (2001) S54-S57
2. Slatopolsky E., Brown A., and Dusso A. Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl 73 (1999) S14-S19
3. Denda M., Finch J., and Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28 (1996) 596-602
4. Dusso A.S., Pavlopoulos T., Naumovich L., et al. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 59 (2001) 855-865
5. Gogusev J., Duchambon P., Stoermann-Chopard C., et al. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 11 (1996) 2155-2162
6. Cozzolino M., Lu Y., Finch J., Slatopolsky E., and Dusso A.S. p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60 (2001) 2109-2117
7. Cozzolino M., Lu Y., Sato T., et al. A critical role for enhanced-TGF{alpha} and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol 289 (2005) F1096-F1102
8. Baldwin B.R., Timchenko N.A., and Zahnow C.A. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol Cell Biol 24 (2004) 3682-3691
9. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365 (2002) 561-575
10. Lamb J., Ramaswamy S., Ford H.L., et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114 (2003) 323-334
11. Dhawan P., Peng X., Sutton A.L., et al. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase. Mol Cell Biol 25 (2005) 472-487
12. Fukuda N., Tanaka H., Tominaga Y., Fukagawa M., Kurokawa K., and Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92 (1993) 1436-1443
13. Cordero J.B., Cozzolino M., Lu Y., et al. 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem 277 (2002) 38965-38971
14. Ji Y., and Studzinski G.P. Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. Cancer Res 64 (2004) 370-377